Valuation: BioNexus Gene Lab Corp.

Market Cap 1.99M 1.82M 1.67M 1.52M 2.86M 185M 3M 20.37M 8.1M 101M 7.48M 7.33M 317M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value -1.82M -1.66M -1.53M -1.39M -2.61M -168M -2.74M -18.58M -7.39M -92.02M -6.83M -6.68M -289M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
46.42%
Yield 2024 *
-
Yield 2025 -
1 week-17.17%
Current month-25.89%
1 month-43.57%
3 months-57.14%
6 months-67.46%
Current year-82.78%
1 week 0.62
Extreme 0.621
0.82
1 month 0.62
Extreme 0.621
1.19
Current year 0.62
Extreme 0.621
4.14
1 year 0.62
Extreme 0.621
4.97
3 years 0.62
Extreme 0.621
33.9
5 years 0.62
Extreme 0.621
267.6
10 years 0.62
Extreme 0.621
414
Manager TitleAgeSince
Chief Executive Officer 43 11/12/2023
Director of Finance/CFO 63 17/06/2025
Director TitleAgeSince
Director/Board Member 71 07/03/2022
Director/Board Member 43 11/12/2023
Director/Board Member 51 11/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Free

Director

32,258 1.0997%
13/08/26 Free

Chief Executive Officer

338,709 11.5465%
13/08/26 Free

Director

16,129 0.5498%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-17.17%-84.37%-82.45% 1.99M
-2.49%-3.76%+50.31%+62.10% 63.66B
-0.63%-2.91%+6.20%+89.22% 58.56B
-2.37%-2.22%+22.87%+82.31% 54.19B
-2.19%-6.15%+11.92%+108.08% 44.66B
-1.89%-7.28%+13.22%+19.74% 40.51B
-0.93%-0.47%+19.73%+43.75% 36.27B
+1.11%-6.44%+130.68%+641.83% 34.89B
-0.80%+0.61%+77.26%+56.26% 32.26B
-2.17%+16.65%-29.21%+474.05% 31.01B
Average -1.24%-2.81%+21.86%+149.49% 40B
Weighted average by Cap. -1.48%-1.85%+32.16%+150.90%

Financials

2024 2025
Net sales 9.51M 8.66M 7.98M 7.26M 13.62M 881M 14.32M 97.14M 38.61M 481M 35.68M 34.93M 1.51B 7.42M 6.76M 6.23M 5.67M 10.63M 688M 11.18M 75.84M 30.14M 376M 27.86M 27.27M 1.18B
Net income -1.6M -1.46M -1.34M -1.22M -2.29M -148M -2.41M -16.33M -6.49M -80.84M -6M -5.87M -254M -2.98M -2.72M -2.5M -2.28M -4.27M -276M -4.49M -30.49M -12.12M -151M -11.2M -10.96M -474M
Net Debt -4.15M -3.78M -3.48M -3.17M -5.94M -384M -6.25M -42.39M -16.85M -210M -15.57M -15.24M -659M -3.81M -3.47M -3.2M -2.91M -5.46M -353M -5.74M -38.96M -15.48M -193M -14.31M -14.01M -605M
Projected Income Statement - Annual - BioNexus Gene Lab Corp.
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
20/11/26 $0.6800 0.00% 3,075
19/11/26 $0.6800 -7.29% 10,438
18/11/26 $0.7335 -4.27% 2,338
17/11/26 $0.7662 -6.56% 14,002
16/11/26 $0.8200 -0.12% 2,179
  1. Stock Market
  2. Stocks
  3. BGLC Stock